Research
& Development

Ipsen’s commitment to research & development is our bold promise to patients, to launch at least one new drug or meaningful new indication every year. We will secure our future by building a pipeline of innovative medicines, establishing our leadership position in key therapeutic areas, ensuring sustainable lifecycle management and, most importantly, creating a company of inspiring people throughout our R&D organization.

The patient voice helps us design clinical trials and provide effective therapeutic solutions. Our R&D centers are at the heart of three internationally reputed scientific hubs; Paris-Saclay in France, Cambridge in the U.S.A. and Oxford in the U.K.

R&D at a glance

Ipsen’s commitment to research & development is our bold promise to patients to launch at least one new drug or meaningful new indication every year. We will secure our future by building a pipeline of innovative medicines, establishing our leadership position in key therapeutic areas, ensuring sustainable lifecycle management and, most importantly, creating a company of inspiring people throughout our R&D organization.

Learn more

Our R&D Strategy

As a global biopharmaceutical company, with a focus on innovation and specialty care, we have the ambition to build a robust, valuable and sustainable portfolio of innovative medicines to meet our patient’s needs. Our R&D strategy is guided by our end goal to ensure that we bring innovative medicines to market as quickly as possible to address unmet patient needs in the areas of Oncology, Neuroscience and Rare Diseases.

Learn more

Three therapeutic areas

Ipsen focuses on three therapeutic areas, Oncology, Neuroscience and Rare Diseases, developing innovative and differentiated therapies in areas of high unmet medical need. Our specialized portfolio of products, combined with our strong clinical and regulatory skillset, will allow us to continue to expand indications across existing therapies and bring new treatments to patients.

Oncology

Rare diseases

Neuroscience

Pipeline

Ipsen’s R&D has a valuable pipeline encompassing both lifecycle management of our well-established products and the development of innovative new molecules, including small molecules, neurotoxins and theranostics.

Learn more

Clinical Trials

Our biotech mindset, combined with the scale and advantages of a global pharmaceutical company, has established us as a development powerhouse in our core areas of focus. We have therapeutically-aligned teams, global expertise in regulatory affairs, patient safety and medical affairs, and a proven ability to bring new, life changing therapies successfully through clinical development.

Learn more

Our R&D Specialisms

Ipsen has a leading-edge technological platform in toxins, in which we stand out for our acknowledged expertise. This specialist knowledge also opens the door to the possibility of strong external partnerships in the field. With their unique properties, toxin molecules offer potential in the treatment of neuromuscular disorders, as well as for pain and aesthetic medicine.

Learn more